Characterization of Mycobacterium tuberculosis of Lebanese patients by double-repetitive-element polymerase chain reaction;Caractérisation de Mycobacterium tuberculosis chez des patients libanais par PCR d'éléments répétitifs doubles

Eastern Mediterranean Health Journal

Volumn 16, Issue 8, 2010, Pages 812-819

  Hamze, M ^a   Rahmo, A ^b   Saade, M ^c  

^a LEBANESE UNIVERSITY   (Libyan Arab Jamahiriya)

^b National Commission for Biotechnology   (Syrian Arab Republic)

^c MINISTRY OF PUBLIC HEALTH   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DOUBLE REPETITIVE ELEMENT POLYMERASE CHAIN REACTION; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION SENSITIVITY; LEBANON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEX DIFFERENCE; SPUTUM CULTURE; STRAIN DIFFERENCE;

EID: 77955805950     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.8.812     Document Type: Article

References (21)

1. Zigol M et al. Global incidence of multidrug-resistant tuberculosis. Journal of Infectious Diseases, 2006, 194:479-485.
2. Senol G, Komurcuoglu B, Komurcuoglu A. Drug resistance of Mycobacterium tuberculosis in Western Turkey: a retrospective study from 1100-bed teaching hospital. Journal of Infection, 2005, 50(4):306-311.
3. Verver S et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. American Journal of Respiratory and Critical Care Medicine, 2005, 171:1430-1435.
4. Martínez M et al. Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis. Journal of Clinical Microbiology, 2006, 44(8):2967-2969.
5. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerging Infectious Diseases, 2006, 2(5):736-743.
6. Clark CM et al. Universal genotyping in tuberculosis control program, New York City, 2001-2003. Emerging Infectious Diseases, 2006, 12(5):719-724.
7. Montoro E, Valdivia J, Leão SC. Molecular fingerprinting of Mycobacterium tuberculosis isolates obtained in Havana, Cuba, by IS6110 restriction fragment length polymorphism analysis and by the double-repetitive-element PCR method. Journal of Clinical Microbiology, 1998, 36:3099-3102.
8. Sola C et al. Spoligotyping followed by double-repetitiveelement PCR as a rapid alternative to IS6110 fingerprinting for epidemiological studies in tuberculosis. Journal of Clinical Microbiology, 1998, 36:1122-1124.
9. Zapata P, Arbeloa M, Aznar J. Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis inoculated from clinical specimens. Clinical Microbiology and Infection, 1999, 5:227-230.
10. Shinnick TM, Good RC. Mycobacterial taxonomy. European Journal of Clinical Microbiology & Infectious Diseases, 1994, 13(11):884-901. References
11. Harris EA, Kadir N, eds. A low-cost approach to PCR. Appropriate transfer of biomolecular techniques. Oxford, Oxford University Press, 1998.
12. Friedman CD et al. Double-repetitive-element PCR method for subtyping Mycobacterium tuberculosis clinical isolates. Journal of Clinical Microbiology, 1995, 33:1383-1384.
13. Karim F et al. Gender differences in delays in diagnosis and treatment of tuberculosis. Health Policy and Planning, 2007, 22(5):329-334.
14. Hamid Salim MA et al. Gender differences in tuberculosis: a prevalence survey done in Bangladesh. International Journal of Tuberculosis and Lung Disease, 2004, 8(8):952-957.
15. Araj G, Saade H, Itani L. Nationwide study of drug resistance among acid-fast baulle positive pulmonary tuberculosis cases in Lebanon. International Journal of Tuberculosis and Lung Disease, 2006, 10(1):63-67.
16. Hamze M, Araj G. Drug resistance among mycobacterium tuberculosis isolates in Lebanon. International Journal of Tuberculosis and Lung Disease, 1997, 1(4):314-318.
17. Gagneux S et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathogens, 2006, 2(6):603-610.
18. McShane H. Susceptibility to tuberculosis-the importance of the pathogen as well as the host. Clinical and Experimental Immunology, 2003, 133:20-21.
19. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Current Opinion in Microbiology, 2006, 9:461-465.
20. Tanaka MM, Rosenberg NA, Small PM, The control of copy number of IS6110 in Mycobacterium tuberculosis. Molecular Biology and Evolution, 2004, 21:2195-2201.
21. Kalaajieh WK. Epidemiology of tuberculosis in Lebanon. International Journal of Tuberculosis and Lung Disease, 1999, 3(9):774-777.